These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. The effects of the H1 and H2 antihistamines on "allergic" histamine release and its inhibition by histamine. Lichtenstein LM; Gillespie E J Pharmacol Exp Ther; 1975 Feb; 192(2):441-50. PubMed ID: 46921 [TBL] [Abstract][Full Text] [Related]
24. Cetirizine inhibition of histamine-induced bronchospasm. Tashkin DP; Brik A; Gong H Ann Allergy; 1987 Dec; 59(6 Pt 2):49-52. PubMed ID: 2892450 [TBL] [Abstract][Full Text] [Related]
25. Effect of H1-antihistamines on histamine release from dispersed canine cutaneous mast cells. García G; DeMora F; Ferrer L; Puigdemont A Am J Vet Res; 1997 Mar; 58(3):293-7. PubMed ID: 9055977 [TBL] [Abstract][Full Text] [Related]
26. [Effect of cetirizine, selective H1 antagonist of histamine on skin and bronchial reactivity and cellular histamine release in allergic diseases]. Siergiejko Z; Michalska I; Rogalewska A; Chyrek-Borowska S Pneumonol Alergol Pol; 1992; 60(11-12):22-7. PubMed ID: 1303774 [TBL] [Abstract][Full Text] [Related]
27. Effects of bepotastine, cetirizine, fexofenadine, and olopatadine on histamine-induced wheal-and flare-response, sedation, and psychomotor performance. Takahashi H; Ishida-Yamamoto A; Iizuka H Clin Exp Dermatol; 2004 Sep; 29(5):526-32. PubMed ID: 15347340 [TBL] [Abstract][Full Text] [Related]
28. Central effects of fexofenadine and cetirizine: measurement of psychomotor performance, subjective sleepiness, and brain histamine H1-receptor occupancy using 11C-doxepin positron emission tomography. Tashiro M; Sakurada Y; Iwabuchi K; Mochizuki H; Kato M; Aoki M; Funaki Y; Itoh M; Iwata R; Wong DF; Yanai K J Clin Pharmacol; 2004 Aug; 44(8):890-900. PubMed ID: 15286093 [TBL] [Abstract][Full Text] [Related]
29. Cutaneous drug eruption from cetirizine and hydroxyzine. Lew BL; Haw CR; Lee MH J Am Acad Dermatol; 2004 Jun; 50(6):953-6. PubMed ID: 15153902 [TBL] [Abstract][Full Text] [Related]
30. [Intradermal tests using vasomotor agents in allergic rhinitis]. Milosević DN; Janosević LjB; Janosević SB Srp Arh Celok Lek; 2000; 128(11-12):357-62. PubMed ID: 11337913 [TBL] [Abstract][Full Text] [Related]
32. Antihistamines and allergic asthma. De Vos C Allerg Immunol (Paris); 1991 Nov; 23(9):396-401. PubMed ID: 1685322 [TBL] [Abstract][Full Text] [Related]
33. [Comparative activity of antihistamines on area under dose-response curve from histamine-induced wheal and flare responses in human skin]. Wang RQ; Zhang HY Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Dec; 26(6):634-8. PubMed ID: 15663222 [TBL] [Abstract][Full Text] [Related]
34. Suppression of wheal and flare in histamine test by the main H1 antihistamines commercialized in Brazil. Maciel-Guerra H; Penha MÁ; Jorge MFS; Libório RDS; Carrijo ACNDA; Parise-Fortes MR; Miot HA An Bras Dermatol; 2018 Mar; 93(2):233-237. PubMed ID: 29723372 [TBL] [Abstract][Full Text] [Related]
35. H1-antihistamines in asthma. Lordan JL; Holgate ST Clin Allergy Immunol; 2002; 17():221-48. PubMed ID: 12113218 [TBL] [Abstract][Full Text] [Related]
36. H1-antihistamines and the central nervous system. Welch MJ; Meltzer EO; Simons FE Clin Allergy Immunol; 2002; 17():337-88. PubMed ID: 12113223 [TBL] [Abstract][Full Text] [Related]
38. Advances in the pharmacotherapy of allergic rhinitis: second-generation H1-receptor antagonists. Corey JP Otolaryngol Head Neck Surg; 1993 Sep; 109(3 Pt 2):584-92. PubMed ID: 8105440 [TBL] [Abstract][Full Text] [Related]
39. Treatment for allergic rhinitis and chronic idiopathic urticaria: focus on oral antihistamines. Morgan MM; Khan DA; Nathan RA Ann Pharmacother; 2005 Dec; 39(12):2056-64. PubMed ID: 16278258 [TBL] [Abstract][Full Text] [Related]